coalition: glofitamab r-chop or glofitamab pola-r-chp in patients with high-risk dlbcl
Published 1 year ago • 457 plays • Length 6:12Download video MP4
Download video MP3
Similar videos
-
3:48
coalition: glofitamab r-chop or glofitamab pola-r-chp in high-risk dlbcl
-
5:30
how the treatment landscape of dlbcl is changing: r-chop vs pola-r-chp
-
4:16
glofitamab plus r-chop in patients with high-risk lbcl: a phase ii trial
-
2:40
phase ii study of glofitamab in patients with r/r lbcl
-
2:21
impact of tmtv on pfs following glofitamab treatment in r/r dlbcl
-
3:58
extended follow-up of glofitamab monotherapy in r/r lbcl: durability of cr and likelihood of crs
-
4:46
glofitamab induces durable complete remissions in patients with relapsed large b-cell lymphoma
-
10:09
understanding diffuse large b-cell lymphoma with jennifer amengual, md
-
6:23
the benefits of bispecific antibodies over car-t cell therapy in lymphoma
-
4:54
imugene reports promising results in phase 1b trial for azer-cel in dlbcl
-
2:04
the starglo trial: glofitamab in combination with gemcitabine and oxaliplatin in r/r dlbcl
-
1:44
remodl-b: bortezomib r-chop versus r-chop in patients with dlbcl
-
2:15
frontmind: tafasitamab lenalidomide r-chop vs r-chop for newly diagnosed high-risk dlbcl
-
3:53
frontmind: tafasitamab lenalidomide r-chop vs r-chop in high-intermediate & high-risk dlbcl
-
2:33
glofitamab as a single agent in heavily pretreated patients with dlbcl
-
1:17
globryte: investigating glofitamab monotherapy in patients with r/r mcl
-
1:45
a phase i/ii trial of glofitamab monotherapy in r/r mcl
-
2:54
updated results of glofitamab plus polatuzumab vedotin combination therapy in dlbcl, including hgbcl
-
2:33
mitigating crs following glofitamab treatment in r/r dlbcl
-
5:44
glofitamab and obinutuzumab in r/r mcl
-
1:46
phase i study of costimulatory bispecific antibody ro7227166 combined with glofitamab in r/r b-nhl
-
1:58
ash highlights: glofitamab in dlbcl & pirtobrutinib and epcoritamab in richter's transformation